Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
IPC issues alert against adverse reactions of painkiller Meftal
The commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of…
Fortifying Brand India Pharma
Lessons and insights on measures and approaches to drive innovation, quality and growth in India's pharma sector from industry…
Charting India Pharma Inc’s growth path
Pharma leaders and experts highlight opportunities in the life sciences industry, address critical issues and explore development…
Madrigal’s efforts for resmetirom will set tone for future launches of NASH therapies: GlobalData
In December 2022, the company successfully concluded raising a total of $309 million following positive topline data from the…
Merck announces Remarkable Merck Young Scientists Awards 2023
Held at Bangalore, the annual awards recognise the work of young scientists who are driving positive change in the lives of…
Indoco Remedies gets tentative USFDA approval for Canagliflozin Tablets
Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus
Zydus gets final USFDA nod for Methylene Blue Injection
Methylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired…
Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharma market in GCC region, Philippines happens to be the second largest market in South East…
AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023
The International Agency for Research on Cancer (IARC) forecasts a 58 per cent surge in GI cancer cases by 2040 globally
Sentynl completes asset transfer of CUTX-101 Copper Histidinate product candidate for treatment of…
A rolling submission of the CUTX-101 New Drug Application (NDA) to the FDA is ongoing, with expected completion in 2024